Candidate for Region IX: Regional Director
1. What are your greatest contributions to ASAM and the field of addiction medicine?
My greatest contributions to ASAM are in the area of continuing education. I am most proud of my role as Chair of the Fundamentals of Addiction Medicine since 2013 and being part of the group responsible for the transformation of the core offerings. We now have a highly rated and evaluated course with the creation of a recognition program for those practitioners who complete 40 hours of accredited learning in Addiction Medicine. I am especially proud of creating a culture of collaboration with the faculty and the space for innovation in the development and delivery of content. We have increased the amount of case-based, interactive learning and have advanced the use of technology to enhance the opportunities for learning. In partnership with ASAM Staff and other ASAM members and being the Vice-chair of the Medical Education Council, I believe my contributions have helped in positioning ASAM as a leader in addictions training for a variety of health care providers. I am also a member of the Publications Council serving as a liaison between the education and publication councils. I have been involved in key decisions regarding the choice for editors of JAM, the ASAM weekly and books under development. In addition, I have been a member of the examination committee from 2000 responsible for the development of test items, improving test items, setting, and reviewing exams. I have continued to be involved in the examination committee since its transition to ABAM. Lastly, I have been a presenter at the annual conference on several occasions and have also chaired the Perinatal Addiction Committee from 2003. I had provided expert comments in several amicus briefs for pregnant women being prosecuted for their addiction in the US.
My contributions to the field of addiction medicine have been in the area of research, clinical care, education and leadership. In the first half of my career, I focused on pregnancy and substance use especially opioid use disorder and in the latter half on tobacco use especially in populations with high prevalence such as those with other addictions and mental illness. In total, I have received grant funding totaling over 73 million dollars from CIHR, NIH, and the Ontario Ministry of Health and have published 131 peer-reviewed publications. I have published 5 books (including 4 edited), authored 30 book chapters, and 32 research reports prepared for the government. I am the Co-Chair for the Ontario Ministry of Health Tobacco Cessation Task Force and since 2000 have guided national and provincial strategies to address tobacco use and addiction. In addition, I am the Co-Chair of the Canadian Centre for Substance Abuse National Task Force on Treatment for Prescription Drug Misuse. I have developed the Centre for Addiction and Mental Health fellowship programs in Addiction Medicine and Psychiatry, which are ABAM accredited and have received funding from the hospital and Ministry of Health to support up to 6 positions. Through this fellowship program, I have trained a variety of physicians from Canada and international settings such as Saudi Arabia, Tanzania, Israel, France and Oman. In addition, I am the Chair of the Royal College of Physicians and Surgeons of Canada, an area of focused competence in Addiction Medicine. I mentor Fellows in Addiction Medicine and Addiction Psychiatry, junior investigators and medical students. I also direct a graduate course on health behaviour change and an undergraduate course in addiction for psychology students at the University of Toronto. I use innovative methods to communicate messages about addictive disorders and have been invited to make presentations to federal government senate committees as well as over 500 media appearances.
I am particularly proud of my success in implementation in primary and community settings in Ontario. The internationally accredited, award winning Training Enhancement in Applied Cessation Counseling and Health certificate program that I developed in 2005 has trained over 5000 health care practitioners from over 45 disciplines in the treatment of tobacco addiction in a variety of settings including addiction treatment settings. In addition, I have partnered with over 340 primary care settings and 51 community addiction treatment programs to implement tobacco addiction treatment. At last count, my program has engaged and treated over 170,000 Ontarians in the last 11 years.
2. How would your election benefit ASAM and the field of addiction medicine?
As described above, my skills as an academic addiction medicine physician with deep expertise in the field, coupled with my research, education, administrative and policy experience could be even more beneficial to ASAM’s mission and goals.
For example, I already play in role in Canada to increase access to and improve the quality of addiction treatment by working with national and provincial agencies responsible for standards and programs of care. As described above, I play a key role in the education of physicians (including medical and osteopathic students), other health care providers and the public both within ASAM and in Canada. As a researcher in addiction with a focus on tobacco addiction and its comorbidities, I play a key role in furthering the treatment of addiction and prevention of secondary problems in mental and physical health. I train fellows and mentor other physicians and advocate at a system level in Canada for the recognition and establishment of addiction medicine as a specialty recognized by professional organizations, governments, physicians, purchasers and consumers of health care services, and the general public.
As an ASAM director, I will be able to better advocate in international settings for the above, broker collaborations between other international organizations and ASAM. In addition, I could promote the excellent work and education offerings and products to a broader audience around the world.
In summary, if elected as a director, I believe my contributions will benefit both ASAM and the field of Addiction Medicine.
Peter Selby MD is the Director of Medical Education and a Clinician Scientist at the Centre for Addiction and Mental Health (CAMH). He is a Professor in the Departments of Family and Community Medicine, Psychiatry, and the Dalla Lana School of Public Health at the University of Toronto. He is also a Clinician Scientist in the Department of Family and Community Medicine. Dr. Selby is the executive director and creator of the TEACH project - a continuing education certificate program in Applied Counselling for Health with a focus on smoking cessation, through the University of Toronto. Dr. Selby’s research, as a Principal Investigator at the Ontario Tobacco Research Unit, includes smoking cessation especially in smokers with co morbid conditions. As the Principal Investigator of the STOP study, he investigates effectiveness of NRT and counselling in different types of intervention settings. He is also the PI of CANADAPTT- a unique Canadian Smoking Cessation Guideline development and dissemination project. Dr. Selby also continues his clinical research with pregnant women who use substances and is the PI of a knowledge translation program (PREGNETS) to increase the adoption of evidence-based interventions with pregnant smokers.
He has received grant funding totaling over 65 million dollars from CIHR, NIH, and Ministry of Health and has published 117 peer reviewed publications. He has published 5 books (including 4 edited), is the author of 27 book chapters, and 12 research reports prepared for the government. He is the Co-Chair for the Ministry of Health Cessation Task force and the Chair of the Canadian Centre for Substance Abuse National Task Force on Treatment for Prescription Drug Misuse. Dr. Selby mentors Fellows in Addiction Medicine and Addiction Psychiatry, junior investigators and medical students. The use of innovative methods to communicate messages makes Dr. Selby a sought after speaker for various topics including addictive disorders, motivational interviewing, and health behavior change.